{"denomUnitsSelected":"Participants","description":"According to the International Myeloma Working Group (IMWG) Uniform Response Criteria for Multiple Myeloma:\n\nOverall Survival (OS)-Duration of survival from time of treatment with P-BCMA-101.","reportingStatus":"NOT_POSTED","timeFrame":"Baseline through Month 24","title":"Phase 1: Anti-myeloma Effect of P-BCMA-101 (OS)","type":"SECONDARY"}